Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2025)

NeuroPace has reported Amortization of Deferred Charges over the past 6 years, most recently at $237000.0 for Q4 2025.

  • Quarterly results put Amortization of Deferred Charges at $237000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $337000.0 (down 62.13% YoY), and the annual figure for FY2025 was $237000.0, down 82.94%.
  • Amortization of Deferred Charges for Q4 2025 was $237000.0 at NeuroPace, up from $100000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for NPCE hit a ceiling of $690000.0 in Q1 2024 and a floor of -$1.0 million in Q4 2022.
  • Median Amortization of Deferred Charges over the past 5 years was $100000.0 (2021), compared with a mean of $142500.0.
  • Biggest five-year swings in Amortization of Deferred Charges: crashed 1623.88% in 2022 and later soared 167.48% in 2023.
  • NeuroPace's Amortization of Deferred Charges stood at $67000.0 in 2021, then crashed by 1623.88% to -$1.0 million in 2022, then soared by 167.48% to $689000.0 in 2023, then plummeted by 85.49% to $100000.0 in 2024, then skyrocketed by 137.0% to $237000.0 in 2025.
  • The last three reported values for Amortization of Deferred Charges were $237000.0 (Q4 2025), $100000.0 (Q2 2025), and $100000.0 (Q3 2024) per Business Quant data.